Home › Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca
 

Keywords :   


Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca

2014-01-03 11:53:31| Biotech - Topix.net

Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca .

Tags: program transfers inhibitor astrazeneca

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »